Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tarylee Reddy

Showing results (61-70 of 123) with videos related to

Pageof 13
Sort By:
Virology Journal|April 8, 2025
Genetic determinants of HIV-1 subtype C Nef-mediated SERINC3 down-regulationNikeisha Samlall, Tarylee Reddy, Nasreen Ismail, et al.
Southern African Journal of HIV Medicine|March 24, 2018
PIMA™ point-of-care testing for CD4 counts in predicting antiretroviral initiation in HIV-infected individuals in KwaZulu-Natal, Durban, South AfricaMandisa Skhosana, Shabashini Reddy, Tarylee Reddy, et al.
Vaccines|October 28, 2023
Factors Associated with COVID-19 Vaccine Uptake among Schoolgoing Adolescent Girls and Young Women in South AfricaKate Bergh, Kim Jonas, Zoe Duby, et al.
BMC Pharmacology & Toxicology|November 20, 2014
Randomized pharmacokinetic evaluation of different rifabutin doses in African HIV- infected tuberculosis patients on lopinavir/ritonavir-based antiretroviral therapySuhashni Naiker, Cathy Connolly, Lubbe Wiesner, et al.
Diagnostics (Basel, Switzerland)|February 7, 2020
Assessment of the Impact of Rapid Point-of-Care CD4 Testing in Primary Healthcare Clinic Settings: A Survey Study of Client and Provider PerspectivesShabashini Reddy, Andrew Gibbs, Elizabeth Spooner, et al.
Antimicrobial Agents and Chemotherapy|October 21, 2015
Effect of SLCO1B1 Polymorphisms on Rifabutin Pharmacokinetics in African HIV-Infected Patients with TuberculosisStefanie Hennig, Suhashni Naiker, Tarylee Reddy, et al.
AIDS Research and Therapy|December 15, 2021
Trends and correlates of HIV prevalence among adolescents in South Africa: evidence from the 2008, 2012 and 2017 South African National HIV Prevalence, Incidence and Behaviour surveysMusawenkosi Mabaso, Goitseone Maseko, Ronel Sewpaul, et al.
Journal of Global Health|February 9, 2022
Point-of-care CD4 testing: Differentiated care for the most vulnerableElizabeth Spooner, Tarylee Reddy, Nobuhle Mchunu, et al.
Vaccines|August 26, 2022
South African University Staff and Students' Perspectives, Preferences, and Drivers of Hesitancy Regarding COVID-19 Vaccines: A Multi-Methods StudyGavin George, Michael Strauss, Emma Lansdell, et al.
Frontiers in Public Health|September 11, 2025
Psychosocial and behavioral factors associated with HIV among adolescent girls and young women in DREAMS districts in South Africa: cross-sectional surveyKaymarlin Govender, Sean Beckett, Olivier Mukuku, et al.
Pageof 13

Showing results (61-70 of 123) with videos related to

Sort By:
Pageof 13
Virology Journal|April 8, 2025
Genetic determinants of HIV-1 subtype C Nef-mediated SERINC3 down-regulationNikeisha Samlall, Tarylee Reddy, Nasreen Ismail, et al.
Southern African Journal of HIV Medicine|March 24, 2018
PIMA™ point-of-care testing for CD4 counts in predicting antiretroviral initiation in HIV-infected individuals in KwaZulu-Natal, Durban, South AfricaMandisa Skhosana, Shabashini Reddy, Tarylee Reddy, et al.
Vaccines|October 28, 2023
Factors Associated with COVID-19 Vaccine Uptake among Schoolgoing Adolescent Girls and Young Women in South AfricaKate Bergh, Kim Jonas, Zoe Duby, et al.
BMC Pharmacology & Toxicology|November 20, 2014
Randomized pharmacokinetic evaluation of different rifabutin doses in African HIV- infected tuberculosis patients on lopinavir/ritonavir-based antiretroviral therapySuhashni Naiker, Cathy Connolly, Lubbe Wiesner, et al.
Diagnostics (Basel, Switzerland)|February 7, 2020
Assessment of the Impact of Rapid Point-of-Care CD4 Testing in Primary Healthcare Clinic Settings: A Survey Study of Client and Provider PerspectivesShabashini Reddy, Andrew Gibbs, Elizabeth Spooner, et al.
Antimicrobial Agents and Chemotherapy|October 21, 2015
Effect of SLCO1B1 Polymorphisms on Rifabutin Pharmacokinetics in African HIV-Infected Patients with TuberculosisStefanie Hennig, Suhashni Naiker, Tarylee Reddy, et al.
AIDS Research and Therapy|December 15, 2021
Trends and correlates of HIV prevalence among adolescents in South Africa: evidence from the 2008, 2012 and 2017 South African National HIV Prevalence, Incidence and Behaviour surveysMusawenkosi Mabaso, Goitseone Maseko, Ronel Sewpaul, et al.
Journal of Global Health|February 9, 2022
Point-of-care CD4 testing: Differentiated care for the most vulnerableElizabeth Spooner, Tarylee Reddy, Nobuhle Mchunu, et al.
Vaccines|August 26, 2022
South African University Staff and Students' Perspectives, Preferences, and Drivers of Hesitancy Regarding COVID-19 Vaccines: A Multi-Methods StudyGavin George, Michael Strauss, Emma Lansdell, et al.
Frontiers in Public Health|September 11, 2025
Psychosocial and behavioral factors associated with HIV among adolescent girls and young women in DREAMS districts in South Africa: cross-sectional surveyKaymarlin Govender, Sean Beckett, Olivier Mukuku, et al.
Pageof 13